Literature DB >> 15026995

Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction.

Robert C Carlisle1, Tomas Etrych, Simon S Briggs, Jon A Preece, Karel Ulbrich, Leonard W Seymour.   

Abstract

BACKGROUND: Site-specific gene delivery requires vectors that combine stability in the delivery phase with substantial biological activity within target cells. The use of biological trigger mechanisms provides one promising means to achieve this, and here we report a transfection trigger mechanism based on intracellular reduction.
METHODS: Plasmid DNA was condensed with thiolated polyethylenimine (PEI-SH) and the resulting nanoparticles surface-coated using thiol-reactive poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) with 2-pyridyldisulfanyl or maleimide groups, forming reducible disulphide-linked or stable thioether-linked coatings, respectively.
RESULTS: Both sets of polymer-coated complexes had similar size and were stable to a 250-fold excess of the polyanion poly(aspartic acid) (PAA). Reduction with dithiothreitol (DTT) allowed complete release of DNA from disulphide-linked coated complexes, whereas complexes with thioether-linked coating remained stable. Disulphide-linked complexes showed 40-100-fold higher transfection activity than thioether-linked ones, and activity was selectively further enhanced by boosting intracellular glutathione using glutathione monoethyl ester or decreased using buthionine sulfoximine. The chloroquine- and serum-independent transfection activity of disulphide-linked coated complexes suggests this system may provide a viable trigger mechanism to enable site-specific transfection in complex biological settings.
CONCLUSIONS: Linkage of hydrophilic polymer coating to PEI/DNA complexes via reducible disulphide bonds offers a means of fulfilling the contradictory requirements for extracellular stability and intracellular activity. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026995     DOI: 10.1002/jgm.525

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  9 in total

1.  Synthetic PEGylated glycoproteins and their utility in gene delivery.

Authors:  Chang-po Chen; Ji-seon Kim; Dijie Liu; Garrett R Rettig; Marie A McAnuff; Molly E Martin; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2007 Mar-Apr       Impact factor: 4.774

Review 2.  Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.

Authors:  Joel C Sunshine; Corey J Bishop; Jordan J Green
Journal:  Ther Deliv       Date:  2011-04

3.  Crosslinked linear polyethylenimine enhances delivery of DNA to the cytoplasm.

Authors:  Daniel K Bonner; Xiaoyong Zhao; Hilda Buss; Robert Langer; Paula T Hammond
Journal:  J Control Release       Date:  2012-09-18       Impact factor: 9.776

Review 4.  Environmentally responsive peptides as anticancer drug carriers.

Authors:  Suhaas Aluri; Siti M Janib; J Andrew Mackay
Journal:  Adv Drug Deliv Rev       Date:  2009-07-20       Impact factor: 15.470

5.  Breaking up the correlation between efficacy and toxicity for nonviral gene delivery.

Authors:  Miriam Breunig; Uta Lungwitz; Renate Liebl; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

Review 6.  Sheddable coatings for long-circulating nanoparticles.

Authors:  Birgit Romberg; Wim E Hennink; Gert Storm
Journal:  Pharm Res       Date:  2007-06-06       Impact factor: 4.200

Review 7.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

8.  Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells.

Authors:  Fatemeh Talaei; Ebrahim Azizi; Rassoul Dinarvand; Fatemeh Atyabi
Journal:  Int J Nanomedicine       Date:  2011-09-14

Review 9.  Novel delivery methods to achieve immunomodulation.

Authors:  David J Gould; Yuti Chernajovsky
Journal:  Curr Opin Pharmacol       Date:  2007-07-03       Impact factor: 5.547

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.